ANKRD1 and breast cancer: Accordingly, siNUAK2 blocked YAP/TAZ transcriptional activity as assessed using a TEAD-luciferase reporter and by measuring expression of the endogenous target genes, ANKRD1 and CTGF, in two breast cancer lines (Fig. 1c, d and Supplementary Fig. 1a).